Publikationen in Zusammenarbeit mit Forschern von Columbia University (9)

2022

  1. Functional Implications of Intergenic GWAS SNPs in Immune-Related LncRNAs

    Advances in experimental medicine and biology, Vol. 1363, pp. 147-160

2021

  1. Author Correction: Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications (Scientific Reports, (2021), 11, 1, (1526), 10.1038/s41598-021-81093-y)

    Scientific Reports

  2. Genetic landscape of 6089 inherited retinal dystrophies affected cases in Spain and their therapeutic and extended epidemiological implications

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. The T1D-associated lncRNA Lnc13 modulates human pancreatic β cell inflammation by allele-specific stabilization of STAT1 mRNA

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 117, Núm. 16, pp. 9022-9031

2019

  1. Disease-associated SNPs in inflammation-related lncRNAs

    Frontiers in Immunology, Vol. 10, Núm. MAR

2017

  1. Cytoplasmic form of carlr lncRNA facilitates inflammatory gene expression upon NF-kB activation

    Journal of Immunology, Vol. 199, Núm. 2, pp. 581-588

2016

  1. A long noncoding RNA associated with susceptibility to celiac disease

    Science, Vol. 352, Núm. 6281, pp. 91-95

2014

  1. Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials

    Diabetes Technology and Therapeutics

2013

  1. Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicentre, randomised, double-blind, placebo-controlled trials

    The Lancet, Vol. 381, Núm. 9881, pp. 1905-1915